| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8792637 | Journal of Cataract & Refractive Surgery | 2018 | 12 Pages |
Abstract
Diabetic patients who received a subconjunctival injection with triamcinolone acetonide at the end of cataract surgery had a lower macular thickness and macular volume at 6 and 12Â weeks postoperatively than patients who did not. Intravitreal bevacizumab had no significant effect.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Laura H.P. MD, Jan S.A.G. MD, PhD, Bjorn PhD, Frank J.H.M. PhD, Claudette A. MD, Joaquim C.N. MD, PhD, Willem R.O. MD, PhD, Thomas MD, PhD, Marie-José MD, PhD, Maurits V. MD, PhD, Ype P. MD, Zoltán Z. MD, DSc, Alexander H.F. MD, Oliver MD, PhD,